Our team of scientist create algorithms to perform tasks which traditionally rely on human intelligence generating data and analysis arrive at safe and efficacious new drugs faster and at lower cost resulting in profound impact in redefining how scientists develop new drugs, tackle disease, and more. Additionally, blockchain technology is applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, intellectual property (IP), royalties and licensing, ensuring drug authenticity and supply chain compliance

Hentabli Hamza PhD

Co-Founder, Chief Technology Officer

Fatima Boumahdi Ph.D

Chief AI Officer

Fouaz Berrail Ph.D

Director, Computer-Aided-Drug Discovery

Nabila Berrabia

AI Research Scientist

Ghassan Hadj Ahmed

Director, Platform Product Development 

Noureddine Boumahdi

Director, Platform Product Development